Wikidata

(Q63063503)

English

12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.

clinical trial

In more languages

Statements

title
International, Multicenter, Single-arm, Open-label, 12-week Phase IIIb Study to Evaluate RebiSmart™ Suitability for Self Injection of Rebif® New Formulation (RNF) in Multidose Cartridges in Patients With Relapsing Form of Multiple Sclerosis (RMS) (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
sponsor
Merck KGaA
0 references
country
Canada
0 references
Germany
0 references
Italy
0 references
Spain
0 references
Sweden
0 references
start time
July 2008
0 references
end time
January 2009
0 references
number of participants
106
0 references
minimum age
18 year
0 references
maximum age
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63063503&oldid=1857099175"